CCDC126 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.041800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.248200E-01
Normal-vs-Stage2
4.775200E-01
Normal-vs-Stage3
4.780400E-02
Normal-vs-Stage4
1.395620E-01
Stage1-vs-Stage2
5.777800E-01
Stage1-vs-Stage3
8.880300E-02
Stage1-vs-Stage4
5.661600E-02
Stage2-vs-Stage3
2.532800E-01
Stage2-vs-Stage4
1.373840E-02
Stage3-vs-Stage4
3.338500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.563600E-01
Normal-vs-AfricanAmerican
7.804600E-01
Normal-vs-Asian
6.386600E-01
Caucasian-vs-AfricanAmerican
6.413200E-01
Caucasian-vs-Asian
9.630600E-01
AfricanAmerican-vs-Asian
7.137600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.649400E-01
Normal-vs-Female
6.711200E-01
Male-vs-Female
5.964200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.575400E-01
Normal-vs-Age(41-60Yrs)
8.089200E-01
Normal-vs-Age(61-80Yrs)
5.521600E-01
Normal-vs-Age(81-100Yrs)
2.001400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.556600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.930000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.864200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.509600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.082400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.708200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.827600E-01
Normal-vs-Daily Drinker
1.735800E-01
Normal-vs-Weekly Drinker
4.112800E-01
Normal-vs-Occasional Drinker
9.894400E-01
Normal-vs-Social Drinker
9.786000E-01
Non Drinker-vs-Daily Drinker
4.593800E-01
Non Drinker-vs-Weekly Drinker
7.610400E-01
Non Drinker-vs-Occasional Drinker
6.522400E-02
Non Drinker-vs-Social Drinker
2.918400E-01
Daily Drinker-vs-Weekly Drinker
3.825000E-01
Daily Drinker-vs-Occasional Drinker
2.831700E-02
Daily Drinker-vs-Social Drinker
1.686640E-01
Weekly Drinker-vs-Occasional Drinker
2.239200E-01
Weekly Drinker-vs-Social Drinker
4.053600E-01
Occasional Drinker-vs-Social Drinker
9.415400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.778200E-02
Normal-vs-Grade 2
1.039570E-02
Normal-vs-Grade 3
7.700300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.898990E-01
Grade 1-vs-Grade 3
2.258800E-01
Grade 1-vs-Grade 4
9.778200E-02
Grade 2-vs-Grade 3
9.479400E-01
Grade 2-vs-Grade 4
1.039570E-02
Grade 3-vs-Grade 4
7.700300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.718200E-01
Normal-vs-NonDiabetic
6.081200E-01
Diabetic-vs-NonDiabetic
3.036800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.209800E-02
Normal-vs-NoPancreatitis
6.542400E-01
Pancreatitis-vs-NoPancreatitis
1.819690E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.972800E-01
Normal-vs-N1
5.477600E-01
N0-vs-N1
6.891000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.828600E-01
Normal-vs-TP53-NonMutant
8.868400E-01
TP53-Mutant-vs-TP53-NonMutant
9.604500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
